Breaking News, Financial News

Financial Report: Sanofi

Revenues up 7% in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Sanofi 4Q Revenues: €9.1 billion (+7%) 4Q Earnings: €1.8 billion (+1%) FY Revenues: €33.8 billion (+3%) FY Earnings: €6.8 billion (+2%) Comments: Diabetes division sales increased 11% in the quarter to €2.0 billion, driven by Lantus, up 11% to €1.8 billion. Genzyme sales grew 22% to €746 million boosted by MS drug Aubagio (€146 million, up 99%). Sanofi Pasteur sales increased 16% to €1.2 billion driven by influenza vaccines in the U.S. and Emerging Markets as well as the continued recovery ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters